{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:09:44Z","timestamp":1770451784093,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ejpn-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejpn.2018.11.001","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T03:27:52Z","timestamp":1542166072000},"page":"191-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["CSF nerve growth factor (\u03b2-NGF) is increased but CSF insulin-like growth factor-(IGF-1) is normal in children with tuberous sclerosis and infantile spasms"],"prefix":"10.1016","volume":"23","author":[{"given":"Raili","family":"Riikonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5922-7195","authenticated-orcid":false,"given":"Hannu","family":"Kokki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2018.11.001_bib1","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0002-9440(10)62539-4","article-title":"Differential cellular expression of neurotrophins in cortical tubers of the tuberous sclerosis complex","volume":"159","author":"Kyin","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejpn.2018.11.001_bib2","first-page":"1","article-title":"A role for nerve growth factor in nervous system, endocrine and immune systems","volume":"1","author":"Levi-Montalcini","year":"1990","journal-title":"Prog Neurol Endocrinol Immunol"},{"key":"10.1016\/j.ejpn.2018.11.001_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000087962","article-title":"Nerve growth factor in reproductive biology: link between the immune and nervous system?","volume":"89","author":"Tometten","year":"2005","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.ejpn.2018.11.001_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eplepsyres.2007.10.002","article-title":"Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex","volume":"78","author":"Boer","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ejpn.2018.11.001_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nbd.2015.04.016","article-title":"Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis","volume":"80","author":"Zhang","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.ejpn.2018.11.001_bib6","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/dneu.20778","article-title":"Toward comprehensive neurobiology of IGF-1","volume":"70","author":"Torres-Aleman","year":"2010","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.ejpn.2018.11.001_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fnins.2016.00052","article-title":"IGF-1: a key growth factor that regulates neurogenesis and synaptogenesis from embryonic to adult stages of the brain","volume":"10","author":"Nieto-Estevez","year":"2016","journal-title":"Front Neurosci"},{"key":"10.1016\/j.ejpn.2018.11.001_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSCI-TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.ejpn.2018.11.001_bib9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis","volume":"74","author":"Krueger","year":"2013","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.ejpn.2018.11.001_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrneurol.2016.81","article-title":"The mTOR signalling cascade: paving new roads to cure neurological disease","volume":"12","author":"Crino","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ejpn.2018.11.001_bib11","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIT-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejpn.2018.11.001_bib12","first-page":"F1000","article-title":"New insights into the pathogenesis and prevention of tuberous sclerosis-associated neuropsychiatric disorders (TAND)","volume":"6","author":"Gibson","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.ejpn.2018.11.001_bib13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0887-8994(97)00102-1","article-title":"West syndrome: cerebrospinal fluid nerve growth factor and effect of ACTH","volume":"17","author":"Riikonen","year":"1997","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2018.11.001_bib14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1528-1167.2009.02499.x","article-title":"Insulin-like growth factor 1 is associated with cognitive outcome in infantile spasms","volume":"51","author":"Riikonen","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2018.11.001_bib15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1523\/JNEUROSCI.16-01-00220.1996","article-title":"Persistent dentate granule cell hyperexcitabiliy after neonatal infection with lymphocytic chorionmeningitis virus","volume":"16","author":"Pearce","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.ejpn.2018.11.001_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0887-8994(97)00204-X","article-title":"Overstimulation of nerve growth factors in postinfectious and autoimmune diseases","volume":"18","author":"Riikonen","year":"1998","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2018.11.001_bib17","doi-asserted-by":"crossref","first-page":"14152","DOI":"10.1073\/pnas.93.24.14152","article-title":"Embryonic neuronal markers in tuberous sclerosis; single-cell molecular pathology","volume":"93","author":"Crino","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejpn.2018.11.001_bib18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1017\/S0012162206001605","article-title":"Cerebrospinal fluid insulin-like growth factors IGF-1 and IGF-2 in infantile autism","volume":"48","author":"Riikonen","year":"2006","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.ejpn.2018.11.001_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1469-8749.1990.tb16926.x","article-title":"Tuberous sclerosis and infantile spasms","volume":"32","author":"Riikonen","year":"1990","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.ejpn.2018.11.001_bib20","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/jcp.24607","article-title":"IGF-1 alleviates NMDA-induced excitotoxity in cultured hippocampal neurons against autophagy via the NR2B\/PI3K.AKT-mTOR pathway","volume":"229","author":"Wang","year":"2014","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ejpn.2018.11.001_bib21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1749-6632.2000.tb05392.x","article-title":"Nerve growth factor and neuroimmune interactions in interactions in inflammatory diseases","volume":"917","author":"Stanisz","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.ejpn.2018.11.001_bib22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bbrc.2011.09.094","article-title":"Rapamycin sensitive mTOR activation mediates nerve growth factor (NGF) induced cell migration and pro-survival effects against hydrogen peroxide in retinal pigmential cells","volume":"414","author":"Cao","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejpn.2018.11.001_bib23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.nbd.2011.03.021","article-title":"A pulse rapamycin therapy for infantile spasms and associated cognitive decline","volume":"43","author":"Raffo","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.ejpn.2018.11.001_bib24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/acn3.494","article-title":"Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders","volume":"4","author":"Krueger","year":"2017","journal-title":"Ann Clin Translat Neurol"},{"key":"10.1016\/j.ejpn.2018.11.001_bib25","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1126\/science.7892601","article-title":"Tyrosinase kinase inhibition: an approach to drug development","volume":"267","author":"Levitzki","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ejpn.2018.11.001_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.biochem.75.103004.142657","article-title":"Tyrpostins and other tyrosinase inhibitors","volume":"75","author":"Levitzki","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.ejpn.2018.11.001_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11926-018-0746-0","article-title":"Novel therapeutics in psoriatic arthritis. What is in the pipeline?","volume":"20","author":"Elalouf","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ejpn.2018.11.001_bib28","article-title":"Anti-proliferative effects of GW441756, a novel inhibitor of NGF receptor tyrosine kinase a (TRKA), in human sarcoma","volume":"115","author":"Montagoni","year":"2010","journal-title":"IJEA"},{"key":"10.1016\/j.ejpn.2018.11.001_bib29","doi-asserted-by":"crossref","first-page":"8089","DOI":"10.1038\/s41598-017-06145-8","article-title":"Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers; implications for pathophysiology and treatment","volume":"7","author":"Mills","year":"2017","journal-title":"Sci Rep"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379818300886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379818300886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T10:18:26Z","timestamp":1720779506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379818300886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1090379818300886"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2018.11.001","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF nerve growth factor (\u03b2-NGF) is increased but CSF insulin-like growth factor-(IGF-1) is normal in children with tuberous sclerosis and infantile spasms","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2018.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.","name":"copyright","label":"Copyright"}]}}